Revance Therapeutics Inc (NASDAQ:RVNC)

20.04
Delayed Data
As of 2:41pm ET
 -0.69 / -3.33%
Today’s Change
14.02
Today|||52-Week Range
36.98
+18.30%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close20.73
Today’s open20.76
Day’s range20.01 - 20.76
Volume181,610
Average volume (3 months)142,962
Market cap$496.2M
Dividend yield--
Data as of 2:41pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-408.57%
Earnings growth (this year)-2.06%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.93%
P/E ratioNM
Price/Sales857.68
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
PRQRProQR Therapeutics N...-1.20-5.48%
MRTXMirati Therapeutics ...-0.65-2.22%
LBIOLion Biotechnologies...+0.54+4.46%
VSARVersartis Inc-0.25-1.36%
Data as of 2:56pm ET, 04/01/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$383.0K
Annual profit (last year)-$62.9M
Net profit margin-16,427.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account